Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A new algorithm for determining collimator angles that favor efficiency in MLC based IMRT delivery.

David Wang1, R W Hill, S Lam

  • 1Cancer Care Group, PC, Medical Physics, 950 North Meridian Street, Suite 920, Indianapolis, Indiana 46204, USA.

Medical Physics
|June 12, 2004
PubMed
Summary

A novel algorithm optimizes collimator angles for intensity modulated radiotherapy, significantly reducing treatment segments and monitor units (MUs) without sacrificing plan quality. This enhances delivery efficiency for various cancer types.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Barcoded SARS-CoV-2 viruses define the impact of time and route of transmission on the transmission bottleneck in a Syrian hamster model.

bioRxiv : the preprint server for biology·2024
Same author

Tracking the prevalence and emergence of SARS-CoV-2 variants of concern using a regional genomic surveillance program.

Microbiology spectrum·2024
Same author

Gemykibivirus detection in acute encephalitis patients from Nepal.

mSphere·2024
Same author

Dengue Virus Surveillance in Nepal Yields the First On-Site Whole Genome Sequences of Isolates from the 2022 Outbreak.

bioRxiv : the preprint server for biology·2024
Same author

A randomized controlled trial of alpha phase-locked auditory stimulation to treat symptoms of sleep onset insomnia.

Scientific reports·2024
Same author

Oral docetaxel plus encequidar - a phase 1 clinical trial.

Cancer chemotherapy and pharmacology·2024

Area of Science:

  • Radiation Oncology
  • Medical Physics
  • Computational Biology

Background:

  • Intensity modulated radiotherapy (IMRT) plans require optimization for efficient and high-quality treatment delivery.
  • Current methods for determining optimal collimator angles may not fully maximize delivery efficiency.
  • Reducing treatment time and complexity is crucial for patient comfort and throughput.

Purpose of the Study:

  • To develop and evaluate a new algorithm for determining collimator angles to improve IMRT plan delivery efficiency.
  • To assess the impact of the algorithm on the number of segments and monitor units (MUs).
  • To ensure that plan quality, including target conformity and organ-at-risk sparing, is maintained.

Main Methods:

  • Development of a novel algorithm to calculate optimal collimator angles for IMRT.

Related Experiment Videos

  • Application of the algorithm to prostate and head and neck cancer treatment plans.
  • Comparison of treatment plans generated with the new algorithm versus the Brahme algorithm.
  • Evaluation of plan quality using target conformity index and dose-volume histograms.

    • Main Results:

    • The new algorithm significantly reduced the number of segments and MUs across different treatment sites and beamlet configurations.
    • For a prostate case with a sweeping leaf-sequencer, segment reduction ranged from 5% to 42%, and MU reduction from 10% to 41%.
    • Plan quality, assessed by target conformity and organ-at-risk sparing, remained uncompromised compared to the Brahme algorithm.

    Conclusions:

    • The developed algorithm effectively enhances IMRT delivery efficiency by reducing segments and MUs.
    • The degree of improvement is influenced by target characteristics, modulation levels, and leaf-sequencing algorithms.
    • This approach offers a promising method for optimizing radiotherapy treatments without compromising clinical quality.